- Price is above Fair Value, showing premium demand versus the model.
CVX
PAR
Week ended 07 Aug 2026
Weekly Investor Report
CARVOLIX · Healthcare · Medical Devices
Latest close
6.20 EUR
-4.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is - below the Trend Line and sits at 76.3% of its 52-week range. The latest completed week returned -4.0%, after a -10.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
38
out of 100
Latest Close
6.20 EUR
7 Aug 2026
1W Return
-4.0%
latest completed week
4W Return
-10.1%
short-term follow-through
12W Return
101.3%
quarterly tape
Trend Breadth
0.0%
0 of 28 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 41.36% based on similar historical setup states.
- 3 reversal markers appear in the recent smart-money tape.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-4.0%
Latest completed week; four-week move -10.1%.
Indicator stack
0/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.36%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is - below the Trend Line and sits at 76.3% of its 52-week range. The latest completed week returned -4.0%, after a -10.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5012-week average 0.29
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -10.1% over four weeks, 101.3% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.0%Distance below the 52-week high.
13-week volatility21.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+72.5%Week of 10 Jul.
Worst week-12.5%Week of 17 Jul.
Latest week-4.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains2
Flat weeks1
Modest losses5
Sharp losses10
Recent vol21.0%13-week weekly-return volatility.
Base vol23.9%52-week weekly-return volatility.
Up/down split11/15Count of positive and negative weeks in the 52-week window.
Average skew22.6% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank68 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Devices
4-week rank11 / 13
Group average-5.4%
Trend breadth15.4%
Trend15.4%active weekly trend signals
MD15.4%positive activity pressure
RS15.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.50; 3 reversal markers Next-Week ExpectancyNegative 41.36%Next-week expectancy is negative with a 41.36% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
Orrick advises Carvolix on EUR 30 Million Structured Debt Financing Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6.20 EUR | -4.0% | - | 3.78 EUR | 0.00 | - | 259.4K | Off |
| 31 Jul 2026 | 6.46 EUR | 16.2% | - | 3.69 EUR | 0.00 | - | 287.2K | Off |
| 24 Jul 2026 | 5.56 EUR | -7.9% | - | 3.58 EUR | 0.00 | - | 287.2K | Off |
| 17 Jul 2026 | 6.04 EUR | -12.5% | - | 3.51 EUR | 0.00 | - | 366.2K | Off |
| 10 Jul 2026 | 6.90 EUR | 72.5% | - | 3.40 EUR | 0.00 | - | 1.1M | Off |
| 3 Jul 2026 | 4.00 EUR | 22.0% | - | 3.25 EUR | 0.00 | - | 71.0K | Off |
| 26 Jun 2026 | 3.28 EUR | -7.3% | - | 3.21 EUR | 0.00 | - | 11.3K | Off |
| 19 Jun 2026 | 3.54 EUR | 6.9% | - | 3.21 EUR | 0.00 | - | 14.6K | Off |
| 12 Jun 2026 | 3.31 EUR | -1.5% | - | 3.19 EUR | 0.00 | - | 10.9K | Off |
| 5 Jun 2026 | 3.36 EUR | 1.8% | - | 3.19 EUR | 0.00 | - | 32.2K | Off |
| 29 May 2026 | 3.30 EUR | 6.5% | - | 3.18 EUR | 0.00 | - | 112.1K | Off |
| 22 May 2026 | 3.10 EUR | 0.6% | - | 3.17 EUR | 0.00 | - | 101.1K | Off |
| 15 May 2026 | 3.08 EUR | 0.0% | - | 3.18 EUR | 0.00 | - | 102.0K | Off |
| 8 May 2026 | 3.08 EUR | 8.8% | - | 3.18 EUR | 0.00 | - | 235.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.